drugset / Trial / NCT03657719

A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Elderly Healthy Subjects

NCT03657719

Phase 2 Completed 105 enrolled Green Cross Corporation
RandomizedParallel-groupDouble-blindPrevention

Summary

Elderly healthy subjects will be once administered GC3114A(High-dose Quadrivalent influenza vaccine) or GCFLU Quadrivalent Pre-filled syringe inj..

Timeline

Start
2018-10-01
Primary completion
2018-12-13
Completion
2018-12-13

Drugs

EvaluationDrugModalityDoseRoute
Subject GC3114 Vaccine 0.5 ml Intramuscular
Comparator GCFLU Quadrivalent Vaccine 0.5 ml Intramuscular

Indications